secwatch.observer — SEC 8-K summary
======================================

Issuer:     Grace Therapeutics, Inc. (GRCE)
CIK:        0001444192
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0000950170-24-038882
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acasti Pharma updates corporate presentation; no material new information disclosed
--------------------------------------------------------------------------------

- Updated corporate presentation dated April 1, 2024, furnished as Exhibit 99.1.
- Presentation covers company overview and NASDAQ listing (ACST).
- No financial results, guidance, or operational milestones were announced.
- Presentation is available for investor reference on the company's IR page.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444192/000095017024038882/0000950170-24-038882-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444192/000095017024038882/acst-20240401.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-038882

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer